Analyst Roundup: Wall Street Insiders Offer Insight On The Med-Tech Industry In 2006
This article was originally published in The Gray Sheet
You may also be interested in...
St. Jude Drafts Three-Pronged Plan To Regain ICD Share, Misses Q1 Estimates
St. Jude Medical will launch new ICDs, open new accounts and hire sales people in the hopes of taking share back from on-the-mend ICD manufacturer Boston Scientific/Guidant
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”